Qingmiao Lu
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes 5
- Renal Diseases and Glomerulopathies 5
- Acute Kidney Injury Research 2
- Physiology top 10%
-
- Complement system in diseases 2
-
- Hippo pathway signaling and YAP/TAZ 2
-
- Epigenetics and DNA Methylation 2
- Renal and related cancers 2
-
- Renal cell carcinoma treatment 1
- Co-authors
- Chunsun DaiYuan GuiWeichun HeXian XueJunwei YangXiaoli SunBingyan ShuYan Liang
- Cited by
- NephrologyPhysiologyImmunology
- Partner nations
- ChinaUnited States
In The Last Decade
Qingmiao Lu
15 papers receiving 681 citations
Peers
Comparison fields: 5 of 81
- Nephrology 170
- Physiology 43
- Immunology 187
- Cell Biology 90
- Molecular Biology 319
Countries citing papers authored by Qingmiao Lu
This map shows the geographic impact of Qingmiao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingmiao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingmiao Lu more than expected).
Fields of papers citing papers by Qingmiao Lu
This network shows the impact of papers produced by Qingmiao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingmiao Lu. The network helps show where Qingmiao Lu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qingmiao Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 29 | |
| 3 | 2022 | 29 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 21 | |
| 6 | 2021 | 7 | |
| 7 | 2021 | 21 | |
| 8 | 2020 | 51 | |
| 9 | 2020 | 7 | |
| 10 | 2019 | 36 | |
| 11 | 2018 | 108 | |
| 12 | 2018 | 57 | |
| 13 | 2018 | 31 | |
| 14 | 2017 | 74 | |
| 15 | 2017 | 203 |
About Qingmiao Lu
Qingmiao Lu is a scholar working on Nephrology, Physiology and Gastroenterology, having authored 15 papers that have together received 682 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (5 papers), Renal Diseases and Glomerulopathies (5 papers), Epigenetics and DNA Methylation (2 papers), Renal and related cancers (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Complement system in diseases (2 papers), Acute Kidney Injury Research (2 papers) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Nephrology (170 citations), Physiology (43 citations) and Immunology (187 citations). Qingmiao Lu has collaborated with scholars based in China and United States. Frequent co-authors include Chunsun Dai, Yuan Gui, Weichun He, Xian Xue, Junwei Yang, Xiaoli Sun, Bingyan Shu, Yan Liang, Feng Ye and Mengru Gu.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.